SAN DIEGO, Oct. 21, 2015 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, today announced it will report financial results for the
third quarter 2015 after closing of the NASDAQ Global Market on
Wednesday, November 4, 2015.
A conference call hosted by Dr. Dirk van
den Boom, Interim President and CEO, and other members of
senior management will take place on Wednesday, November 4, 2015, at 5:00 p.m. ET (2:00 p.m.
PT) and will be webcast live on the Sequenom Website.
To access the live teleconference call, dial 877-883-0383 in the
U.S. and Canada, and 412-902-6506
for other international callers. Please use code 0455461. For
interested parties unable to listen to the live conference call, a
replay will be available through Friday,
December 4, 2015. The replay will be accessible by dialing
877-344-7529 or 412-317-0088 international toll or Canada toll free at 855-669-9658, and entering
the conference number 10075290.
The conference call webcast is also accessible through the
"Invest" section of the Sequenom Website at
www.sequenom.com/invest. An online replay will be available
following the initial broadcast until Friday, December 4, 2015.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is committed to enabling healthier
lives through the development of innovative products and services.
The Company serves patients and physicians by providing early
patient management information. To learn how Sequenom is
interpreting the genome to improve your life, visit
www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories™, a CAP-accredited and
CLIA-certified molecular diagnostics laboratory, has developed a
broad range of laboratory-developed tests, with a focus principally
on prenatal care. Branded under the names
HerediT® CF, HerediT®
UNIVERSAL, VisibiliT™,
MaterniT21® PLUS, MaterniT™ GENOME,
and NextView™, these molecular genetic
laboratory-developed tests provide early patient management
information for obstetricians, geneticists, genetic counselors and
maternal fetal medicine specialists. Sequenom Laboratories is
changing the landscape in genetic diagnostics using proprietary
cutting-edge technologies. Visit www.laboratories.sequenom.com and
follow @SequenomLabs.
SEQUENOM®, Sequenom Laboratories™,
HerediT® CF, HerediT® UNIVERSAL,
VisibiliT™, MaterniT21® PLUS,
MaterniT™ GENOME, and NextView™, are
trademarks of Sequenom, Inc. All other trademarks and service marks
are the property of their respective owners.
Logo -
http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-announces-2015-third-quarter-results-conference-call-300163562.html
SOURCE Sequenom, Inc.